30777103|t|H2S suppresses indoleamine 2, 3-dioxygenase 1 and exhibits immunotherapeutic efficacy in murine hepatocellular carcinoma.
30777103|a|BACKGROUND: Over-expression and over-activation of immunosuppressive enzyme indoleamine 2, 3 -dioxygenase 1 (IDO1) is a key mechanism of cancer immune escape. However, the regulation of IDO1 has not been fully studied. The relation between hydrogen sulfide (H2S) and IDO1 is unclear. METHODS: The influences of endogenous and exogenous H2S on the expression of IDO1, iNOS and NF-kappaB and STAT3 signaling proteins were investigated using qPCR or western blot, and the production of nitric oxide (NO) was analyzed by nitrate/nitrite assay in Cse-/- mice and MCF-7 and SGC-7901 cells. The effect of H2S on IDO1 activity was investigated by HPLC and in-vitro enzymatic assay. The effect of H2S on tryptophan metabolism was tested by luciferase reporter assay in MCF-7 and SGC-7901 cells. The correlation between H2S-generating enzyme CSE and IDO1 was investigated by immunostaining and heatmaps analysis in clinical specimens and tissue arrays of hepatocellular carcinoma (HCC) patients. The immunotherapeutic effects of H2S on H22 HCC-bearing mice were investigated. RESULTS: Using Cse-/- mice, we found that H2S deficiency increased IDO1 expression and activity, stimulated NF-kappaB and STAT3 pathways and decreased the expression of NO-generating enzyme Inos. Using IDO1-expressing MCF-7 and SGC-7901 cells, we found that exogenous H2S inhibited IDO1 expression by blocking STAT3 and NF-kappaB pathways, and decreased IDO1 activity via H2S/NO crosstalk, and combinedly decreased the tryptophan metabolism. The negative correlation between H2S-generating enzyme CSE and IDO1 was further validated in clinical specimens and tissue arrays of HCC patients. Additionally, H2S donors effectively restricted the tumor development in H22 HCC-bearing mice via downregulating IDO1 expression, inducing T-effector cells and inhibiting MDSCs. CONCLUSIONS: Thus, H2S, as a novel negative regulator of IDO1, shows encouraging antitumor immunotherapeutic effects and represents a novel therapeutic target in cancer therapy.
30777103	0	3	H2S	Chemical	MESH:D006862
30777103	15	45	indoleamine 2, 3-dioxygenase 1	Gene	15930
30777103	89	95	murine	Species	10090
30777103	96	120	hepatocellular carcinoma	Disease	MESH:D006528
30777103	198	229	indoleamine 2, 3 -dioxygenase 1	Gene	15930
30777103	231	235	IDO1	Gene	15930
30777103	259	265	cancer	Disease	MESH:D009369
30777103	308	312	IDO1	Gene	15930
30777103	362	378	hydrogen sulfide	Chemical	MESH:D006862
30777103	380	383	H2S	Chemical	MESH:D006862
30777103	389	393	IDO1	Gene	3620
30777103	458	461	H2S	Chemical	MESH:D006862
30777103	483	487	IDO1	Gene	3620
30777103	489	493	iNOS	Gene	51477
30777103	498	507	NF-kappaB	Gene	4790
30777103	512	517	STAT3	Gene	6774
30777103	605	617	nitric oxide	Chemical	MESH:D009569
30777103	639	646	nitrate	Chemical	MESH:D009566
30777103	647	654	nitrite	Chemical	MESH:D009573
30777103	664	667	Cse	Gene	107869
30777103	671	675	mice	Species	10090
30777103	680	685	MCF-7	CellLine	CVCL:0031
30777103	690	698	SGC-7901	CellLine	CVCL:0520
30777103	720	723	H2S	Chemical	MESH:D006862
30777103	727	731	IDO1	Gene	15930
30777103	810	813	H2S	Chemical	MESH:D006862
30777103	817	827	tryptophan	Chemical	MESH:D014364
30777103	882	887	MCF-7	CellLine	CVCL:0031
30777103	892	900	SGC-7901	CellLine	CVCL:0520
30777103	932	935	H2S	Chemical	MESH:D006862
30777103	954	957	CSE	Gene	107869
30777103	962	966	IDO1	Gene	3620
30777103	1067	1091	hepatocellular carcinoma	Disease	MESH:D006528
30777103	1093	1096	HCC	Disease	MESH:D006528
30777103	1098	1106	patients	Species	9606
30777103	1141	1144	H2S	Chemical	MESH:D006862
30777103	1148	1151	H22	CellLine	CVCL:1E32
30777103	1152	1155	HCC	Disease	MESH:D006528
30777103	1164	1168	mice	Species	10090
30777103	1203	1206	Cse	Gene	107869
30777103	1210	1214	mice	Species	10090
30777103	1230	1233	H2S	Chemical	MESH:D006862
30777103	1255	1259	IDO1	Gene	15930
30777103	1296	1305	NF-kappaB	Gene	18033
30777103	1310	1315	STAT3	Gene	20848
30777103	1378	1382	Inos	Gene	18126
30777103	1390	1394	IDO1	Gene	3620
30777103	1406	1411	MCF-7	CellLine	CVCL:0031
30777103	1416	1424	SGC-7901	CellLine	CVCL:0520
30777103	1456	1459	H2S	Chemical	MESH:D006862
30777103	1470	1474	IDO1	Gene	3620
30777103	1498	1503	STAT3	Gene	20848
30777103	1508	1517	NF-kappaB	Gene	18033
30777103	1542	1546	IDO1	Gene	15930
30777103	1560	1563	H2S	Chemical	MESH:D006862
30777103	1607	1617	tryptophan	Chemical	MESH:D014364
30777103	1663	1666	H2S	Chemical	MESH:D006862
30777103	1685	1688	CSE	Gene	107869
30777103	1693	1697	IDO1	Gene	3620
30777103	1763	1766	HCC	Disease	MESH:D006528
30777103	1767	1775	patients	Species	9606
30777103	1791	1794	H2S	Chemical	MESH:D006862
30777103	1829	1834	tumor	Disease	MESH:D009369
30777103	1850	1853	H22	CellLine	CVCL:1E32
30777103	1854	1857	HCC	Disease	MESH:D006528
30777103	1866	1870	mice	Species	10090
30777103	1890	1894	IDO1	Gene	15930
30777103	1974	1977	H2S	Chemical	MESH:D006862
30777103	2012	2016	IDO1	Gene	3620
30777103	2117	2123	cancer	Disease	MESH:D009369
30777103	Negative_Correlation	MESH:D006862	3620
30777103	Negative_Correlation	MESH:D006862	18033
30777103	Association	MESH:D014364	15930
30777103	Negative_Correlation	MESH:D006862	15930
30777103	Association	MESH:D006528	15930
30777103	Association	MESH:D006528	3620
30777103	Association	MESH:D006528	107869
30777103	Negative_Correlation	MESH:D006862	MESH:D006528
30777103	Association	MESH:D006862	51477
30777103	Negative_Correlation	MESH:D006862	20848
30777103	Positive_Correlation	MESH:D006862	18126
30777103	Negative_Correlation	MESH:D006862	MESH:D014364
30777103	Association	MESH:D006862	107869
30777103	Association	20848	3620
30777103	Association	MESH:D009369	15930
30777103	Association	MESH:D014364	3620
30777103	Association	MESH:D006862	6774
30777103	Association	18033	3620
30777103	Association	MESH:D006862	4790
30777103	Association	107869	3620

